98 related articles for article (PubMed ID: 17274593)
1. Bilateral gynecomastia with microcalcifications in an HIV infected hemophilia A patient after HAART.
Chalazonitis AN; Theodossiades GD; Nomikou E; Tsevrenis V; Zografos G
JBR-BTR; 2006; 89(6):328. PubMed ID: 17274593
[No Abstract] [Full Text] [Related]
2. HIV-infected hemophilia a patient presenting with gynecomastia.
Chalazonitis A; Sotiropoulou E; Ptohis N; Porfiridis P; Tsiouris S; Tzovara I; Papantoniou V
Diagn Interv Radiol; 2009 Dec; 15(4):242-6. PubMed ID: 19862678
[TBL] [Abstract][Full Text] [Related]
3. Successful percutaneous dihydrotestosterone treatment of gynecomastia occurring during highly active antiretroviral therapy: four cases and a review of the literature.
Benveniste O; Simon A; Herson S
Clin Infect Dis; 2001 Sep; 33(6):891-3. PubMed ID: 11512095
[TBL] [Abstract][Full Text] [Related]
4. Bilateral lipomastia in men: a side effect of highly active antiretroviral therapy.
Deonarain J; Ramdial PK; Singh B
Int J Surg Pathol; 2008 Apr; 16(2):171-5. PubMed ID: 18417674
[TBL] [Abstract][Full Text] [Related]
5. Gynecomastia in HIV-infected patients receiving antiretroviral therapy.
García-Benayas T; Blanco F; Martín-Carbonero L; Valencia E; Barrios A; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):739-41. PubMed ID: 14585204
[TBL] [Abstract][Full Text] [Related]
6. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
Cooper CL; Mills E
Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
[No Abstract] [Full Text] [Related]
8. [Bilateral gynecomastia in a patient with human immunodeficiency virus infection].
Puerta-Fernández S; Belén Ferro-Expósito A; Palacios R; Santos J
Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):600-1. PubMed ID: 19442416
[No Abstract] [Full Text] [Related]
9. Progressive neuropsychiatric problems following institution of highly active antiretroviral therapy.
Miller RF; Dave SS; Tang JW; Shaw PJ; Jäger HR; Wilkins EG
Sex Transm Infect; 2005 Aug; 81(4):351-7. PubMed ID: 16061546
[TBL] [Abstract][Full Text] [Related]
10. [Gynecomastia and HIV infection].
Strub Ch
Praxis (Bern 1994); 2003 Mar; 92(11):507-9. PubMed ID: 12698584
[No Abstract] [Full Text] [Related]
11. Liver ultrastructural morphology and mitochondrial DNA levels in HIV/hepatitis C virus coinfection: no evidence of mitochondrial damage with highly active antiretroviral therapy.
Matsukura M; Chu FF; Au M; Lu H; Chen J; Rietkerk S; Barrios R; Farley JD; Montaner JS; Montessori VC; Walker DC; Côté HC
AIDS; 2008 Jun; 22(10):1226-9. PubMed ID: 18525271
[TBL] [Abstract][Full Text] [Related]
12. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
13. True gynecomastia in congenitally HIV-infected children treated with antiretroviral agents.
Manfredi R; Calza L; Chiodo F
J Chemother; 2004 Jun; 16(3):303-5. PubMed ID: 15330330
[TBL] [Abstract][Full Text] [Related]
14. The nephrologist in the HAART era.
Izzedine H; Deray G
AIDS; 2007 Feb; 21(4):409-21. PubMed ID: 17301559
[No Abstract] [Full Text] [Related]
15. Co-infections. Some good news about HAART and liver health.
TreatmentUpdate; 2008; 20(4):8. PubMed ID: 19248274
[No Abstract] [Full Text] [Related]
16. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Vogel M; Rockstroh JK
Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
[TBL] [Abstract][Full Text] [Related]
17. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
Endo T; Fujimoto K; Nishio M; Yamamoto S; Obara M; Sato N; Koike T
J Med Virol; 2009 Jun; 81(6):979-82. PubMed ID: 19382259
[TBL] [Abstract][Full Text] [Related]
18. Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy.
Piroth L; Grappin M; Petit JM; Buisson M; Duong M; Chavanet P; Portier H
Scand J Infect Dis; 2001; 33(7):559-60. PubMed ID: 11515774
[TBL] [Abstract][Full Text] [Related]
19. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
Burgoyne RW; Tan DH
J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
